← Back to Search

Behavioral Intervention

Smoking Cessation Intervention for Cancer Survivors

Illinois CancerCare-Peru, Peru, IL
Smoking Cessation Intervention +3 morePhase 3RecruitingResearch Sponsored by Alliance for Clinical Trials in Oncology

Study Summary

This trial is testing whether a text-based quitting program can help rural cancer patients who smoke, quit smoking. The program gradually reduces the amount of cigarettes smoked, with the goal of quitting altogether.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You smoke at least 5 cigarettes a day currently.
You own a cell phone or smartphone with texting capability.
You were diagnosed with cancer in the past 10 years and are currently receiving treatment that aims to cure the cancer.
You are not under hospice care currently.
You want to quit smoking and are not currently enrolled in another program to quit smoking.
You are not currently using any medication to help you quit smoking, such as nicotine replacement therapy, bupropion or varenicline. You are also not currently enrolled in a program to help you quit smoking.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months post-quit date
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months post-quit date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically validated tobacco cessation
Secondary outcome measures
Serially measured overall quality of life (QoL) scores obtained at baseline and at 30-days and 6-months post-quite date

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (SGR program, text messages)Experimental Treatment3 Interventions
Patients participate in schedule gradual reduction program over 8 weeks to reduce the frequency of cigarette use. Patients also receive cessation support messages via text messages for 12 weeks.
Group II: Group II (booklet)Active Control1 Intervention
Patients receive NCI's Clearing the Air booklet to help plan to gradually quit smoking.
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention

Find a Location

Who is running the clinical trial?

Alliance for Clinical Trials in OncologyLead Sponsor
510 Previous Clinical Trials
217,635 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,491 Previous Clinical Trials
41,266,969 Total Patients Enrolled
Devon Noonan, PhD, MPH, FNP-BCStudy ChairDuke School of Nursing

Media Library

Text-Based Cessation Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05008848 — Phase 3
Cancer Research Study Groups: Group I (SGR program, text messages), Group II (booklet)
Cancer Clinical Trial 2023: Text-Based Cessation Intervention Highlights & Side Effects. Trial Name: NCT05008848 — Phase 3
Text-Based Cessation Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05008848 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study being conducted in more than one location within the city limits?

"The Carle Foundation Hospital in Urbana, Illinois, Spectrum Health Reed City Hospital in Reed City, Michigan, Illinois, Spectrum Health Reed City Hospital in Reed City, Michigan, and Illinois CancerCare-Galesburg in Galesburg, Iowa are 3 of the 92 locations where this trial is recruiting patients."

Answered by AI

Are recruitment efforts for this clinical trial still underway?

"Recruitment for this clinical trial is ongoing, as seen on clinicaltrials.gov. The listing was first posted December 1st, 2021 and updated August 2nd, 2022."

Answered by AI

How many people are being helped by this experiment?

"In order to gain the desired data, this clinical trial requires 600 participants that meet specific inclusion criteria. Patients can go to The Carle Foundation Hospital in Urbana, Illinois or Spectrum Health Reed City Hospital in Reed City, Michigan, Illinois or Spectrum Health Reed City Hospital in Reed City, Michigan to take part."

Answered by AI

What is the official government stance on this method for quitting smoking?

"There is some evidence to support the efficacy of this smoking cessation intervention, as well as data from multiple rounds of testing that attest to its safety. For these reasons, our team at Power has rated the safety of this intervention a 3."

Answered by AI

Who else is applying?

What state do they live in?
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
Novant Health Cancer Institute - Thomasville
~243 spots leftby Jun 2025